{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:42:26Z","timestamp":1790077346846,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Thrombosis Research Institute"},{"name":"Bayer Pharma AG"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.thromres.2020.04.036","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T11:49:57Z","timestamp":1588074597000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE"],"prefix":"10.1016","volume":"191","author":[{"given":"Henri","family":"Bounameaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo E.","family":"Farjat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Weitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Z.","family":"Goldhaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.G.","family":"Turpie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6821-1504","authenticated-orcid":false,"given":"Shinya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantep","family":"Angchaisuksiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joern Dalsgaard","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Kayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Schellong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo G.","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Prandoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2020.04.036_bb0005","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/jth.12698","article-title":"Thrombosis: a major contributor to the global disease burden","volume":"12","author":"ISTH Steering Committee for World Thrombosis Day","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.04.036_bb0010","doi-asserted-by":"crossref","first-page":"985","DOI":"10.12688\/f1000research.11174.1","article-title":"Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants","volume":"6","author":"Weitz","year":"2017","journal-title":"F1000Research"},{"issue":"12","key":"10.1016\/j.thromres.2020.04.036_bb0015","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.thromres.2020.04.036_bb0020","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.thromres.2020.04.036_bb0025","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.thromres.2020.04.036_bb0030","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"Buller","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.thromres.2020.04.036_bb0035","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"26","key":"10.1016\/j.thromres.2020.04.036_bb0040","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"14","key":"10.1016\/j.thromres.2020.04.036_bb0045","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"Buller","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.thromres.2020.04.036_bb0050","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11239-015-1310-7","article-title":"Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment","volume":"41","author":"Burnett","year":"2016","journal-title":"J. Thromb. Thromb."},{"issue":"2","key":"10.1016\/j.thromres.2020.04.036_bb0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2020.04.036_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/IJGM.S100299","article-title":"Effective management of venous thromboembolism in the community: non-vitamin K antagonist oral anticoagulants","volume":"9","author":"Patel","year":"2016","journal-title":"Int. J. Gen. Med."},{"issue":"6","key":"10.1016\/j.thromres.2020.04.036_bb0065","first-page":"1172","article-title":"Global anticoagulant registry in the field \u2014 venous thromboembolism (GARFIELD-VTE). Rationale and design","volume":"116","author":"Weitz","year":"2016","journal-title":"Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2020.04.036_bb0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/2229-3485.83221","article-title":"Intention-to-treat concept: a review","volume":"2","author":"Gupta","year":"2011","journal-title":"Perspect. Clin. Res."},{"issue":"521","key":"10.1016\/j.thromres.2020.04.036_bb0075","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1080\/01621459.2016.1260466","article-title":"Balancing covariates via propensity score weighting","volume":"113","author":"Li","year":"2018","journal-title":"J. Am. Stat. Assoc."},{"issue":"3","key":"10.1016\/j.thromres.2020.04.036_bb0080","first-page":"67","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J. Stat. Soft."},{"issue":"16","key":"10.1016\/j.thromres.2020.04.036_bb0085","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2016.06.076","article-title":"Anticoagulation during pregnancy: evolving strategies with a focus on mechanical valves","volume":"68","author":"Alshawabkeh","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.thromres.2020.04.036_bb0090","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1016\/S2352-3026(15)00257-4","article-title":"Safety and effectiveness of oral rivaroxaban versus standard anticoagulation for the treatment of symptomatic deep-vein thrombosis (XALIA): an international, prospective, non-interventional study","volume":"3","author":"Ageno","year":"2016","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.thromres.2020.04.036_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.thromres.2019.08.024","article-title":"Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: results from the prospective multicenter START2-Register Study","volume":"183","author":"Poli","year":"2019","journal-title":"Thromb. Res."},{"issue":"34","key":"10.1016\/j.thromres.2020.04.036_bb0100","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e213","article-title":"Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records","volume":"33","author":"Kim","year":"2018","journal-title":"J. Kor. Med. Sci."},{"issue":"10","key":"10.1016\/j.thromres.2020.04.036_bb0105","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/jth.14548","article-title":"Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients","volume":"17","author":"Haas","year":"2019","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2020.04.036_bb0110","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.chest.2019.02.402","article-title":"Extended anticoagulation for VTE: a systematic review and meta-analysis","volume":"155","author":"Mai","year":"2019","journal-title":"CHEST"},{"issue":"9921","key":"10.1016\/j.thromres.2020.04.036_bb0115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.thromres.2020.04.036_bb0120","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.thromres.2020.04.036_bb0125","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.113.002332","article-title":"Management and outcomes of major bleeding during treatment with dabigatran or warfarin","volume":"128","author":"Majeed","year":"2013","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.thromres.2020.04.036_bb0130","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2020.04.036_bb0135","series-title":"TA261","article-title":"Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism","author":"N.I.f.H.a.C. Excellence","year":"2012"},{"key":"10.1016\/j.thromres.2020.04.036_bb0140","series-title":"TA287","article-title":"Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism","author":"N.I.f.H.a.C. Excellence","year":"2013"}],"updated-by":[{"DOI":"10.1016\/j.thromres.2021.11.023","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000}}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820301523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384820301523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:42:03Z","timestamp":1758735723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384820301523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"alternative-id":["S0049384820301523"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2020.04.036","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.thromres.2021.11.023","asserted-by":"object"}]},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2020.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}